NLRP3 inflammasome is regarded as a target of septic cardiomyopathy and its inhibition mediated the cytoprotective effects and improved myocardial function in sepsis-associated myocardial injury [13, 14]. The gene discussed is NLRP3; the disease is Sepsis.